Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 9:40 PM
Ignite Modification Date:
2025-12-24 @ 9:40 PM
NCT ID:
NCT00021632
Eligibility Criteria:
Inclusion Criteria
Patients may be eligible for this study if they:
* Are at least 13 years of age.
* Have written consent from parent or guardian if under 18 years of age.
* Have HIV infection.
* Have been receiving ZDV or d4T for at least 4 weeks prior to study entry.
* Are planning to receive RBV-containing hepatitis treatment through their doctor or through coenrollment in another ACTG protocol within 2 weeks following entry into the study.
* Have not received RBV for at least 6 months prior to study entry if they were previously treated with RBV.
* Weigh more than 110 pounds (50 kg).
Exclusion Criteria
Patients will not be eligible for this study if they:
* Are pregnant.
* Use rifampin, rifabutin, pyrazinamide, isoniazid, ganciclovir, or hydroxyurea within 14 days of study entry.
* Abuse alcohol or drugs. Patients in methadone programs may participate.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
13 Years
Study:
NCT00021632
Study Brief:
Protocol Section:
NCT00021632